104

N,N'-BIS(2-AMINOETHYL)-1,2-ETHANEDIAMINE

Created:1999-12-09
Last modified:  2021-03-01

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count28
Chiral Atom Count0
Bond Count27
Aromatic Bond Count0
2D diagram of 104

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

NameN,N'-BIS(2-AMINOETHYL)-1,2-ETHANEDIAMINE
SynonymsTRIENTINE
Systematic Name (OpenEye OEToolkits)N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine
FormulaC6 H18 N4
Molecular Weight146.234
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs10.04NCCNCCNCCN
SMILESCACTVS3.341NCCNCCNCCN
SMILESOpenEye OEToolkits1.5.0C(CNCCNCCN)N
Canonical SMILESCACTVS3.341 NCCNCCNCCN
Canonical SMILESOpenEye OEToolkits1.5.0 C(CNCCNCCN)N
InChIInChI1.03 InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2
InChIKeyInChI1.03 VILCJCGEZXAXTO-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB06824 
NameTriethylenetetramine
Groups
  • approved
  • investigational
DescriptionTriethylenetatramine (TETA), also known as trientine, is a potent and selective copper (II)-selective chelator. It is a structural analog of linear polyamine compounds, [spermidine] and [spermine]. TETA was first developed in Germany in 1861 and its chelating properties were first recognized in 1925.[A19333] Initially approved by the FDA in 1985 as a second-line treatment for Wilson's disease,[A19334] TETA is currently indicated to treat adults with stable Wilson’s disease who are de-coppered and tolerant to [penicillamine].[L41730] TETA has been investigated in clinical trials for the treatment of heart failure in patients with diabetes.[A18804,A19332,A19333,A19334,A19335]
Synonyms
  • Trientine
  • Triethylenetetramine
  • Trientine hydrochloride
  • Trien
  • Trientine tetrahydrochloride
Brand Names
  • Trientine Hydrochloride
  • Trientine hydrochloride
  • Syprine
  • Mar-trientine
  • Cufence
IndicationTriethylenetetramine is a copper chelator indicated for the treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to [penicillamine].[L41730]
Categories
  • Alimentary Tract and Metabolism
  • Amines
  • Chelating Agents
  • Compounds used in a research, industrial, or household setting
  • Copper Chelator
ATC-CodeA16AX12
CAS number112-24-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Carbonic anhydrase 14MLFSALLLEVIWILAADGGQHWTYEGPHGQDHWPASYPECGNNAQSPIDI...unknowninhibitor
Diamine acetyltransferase 1MAKFVIRPATAADCSDILRLIKELAKYEYMEEQVILTEKDLLEDGFGEHP...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 5565
ChEMBL CHEMBL609
ChEBI CHEBI:39501
CCDC/CSD DAFLAB